source
- Biologics surge drives CMOs and CDMOs to boost sterile fill-finish and prefilled syringe capacityBiologics, biosimilars and GLP-1 therapies are increasing demand for sterile injectable products, prompting contract manufacturers to expand capacity. CMOs and CDMOs are adding fill-finish, lyophi…
- Amgen discloses cybersecurity breach affecting patient dataAmgen reported a cybersecurity incident that resulted in the exfiltration of protected patient health information and other proprietary data stored in cloud services managed by third‑party provider…